Looking for innovation, inspiration and investment when it comes to healthcare? If so, Central Germany is an exciting place to be right now. That was a key ‘take home message’ at the second edition of the ‘future of health xperience’ (FHX24) in Leipzig in May 2024.
BioSquare on the path to completion
The BioSquare at Leipzig’s BioCity Campus for life sciences and technology just celebrated its topping up ceremony in traditional style
Third batch of start-ups at MEDICAL FORGE LEIPZIG
Eight young companies from around the world are now getting that crucial support from the life science accelerator MEDICAL FORGE LEIPZIG
Global POCT Meeting held in Leipzig
Point-of-care-testing (POCT) is a critical part of healthcare, with the potential to improve patient outcomes and expand access to services
BioCity Leipzig: 20 years of success
Guests from near and far gathered to celebrate the 20th anniversary of Leipzig’s incubator and tech hub. What began as a vision is now the nucleus of a thriving life science and tech industry attracting innovators from around the world
Impressions ‘future of health xperience’
A resounding success – that’s what Leipzig’s first ever ‘future of health experience’ (FHX23) turned out to be. More than 450 experts from all areas of healthcare came together to learn and network during the 2-day event.
Green light for biotechnology – Leipzig’s new Innovation Center
All signals GO! Leipzig has launched construction on its centrally-located Innovation Center which is slated to open in 2026.
50 million Euros to expand Institute for Drug Development
After just receiving almost 2 million dollars in funding to establish a digital ‘vaccine library’, Leipzig University’s Institute for Drug Development is celebrating its next windfall.
New vaccine library set to revolutionize pandemic prevention
Upcoming viral threats need a fast response to prevent future pandemics. That’s why Leipzig University is now establishing a digital ‘vaccine library’ so that researchers and clinicians can quickly develop effective vaccines in these situations.
Preclinical and clinical development
Preclinical and clinical development of a novel CAR-T cell therapy for the treatment of multiple myeloma and clear cell renal cell carcinoma.